- Home
- SYRE vs SWIM Comparison
SYRE vs SWIM Comparison
Compare SYRE & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- SWIM
- Stock Information
- Founded
- SYRE 2013
- SWIM 1956
- Country
- SYRE United States
- SWIM United States
- Employees
- SYRE N/A
- SWIM N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- SWIM Plastic Products
- Sector
- SYRE Health Care
- SWIM Industrials
- Exchange
- SYRE Nasdaq
- SWIM Nasdaq
- Market Cap
- SYRE 841.4M
- SWIM 678.4M
- IPO Year
- SYRE 2016
- SWIM 2021
- Fundamental
- Price
- SYRE $15.72
- SWIM $6.65
- Analyst Decision
- SYRE Buy
- SWIM Hold
- Analyst Count
- SYRE 6
- SWIM 4
- Target Price
- SYRE $55.00
- SWIM $6.70
- AVG Volume (30 Days)
- SYRE 673.0K
- SWIM 635.8K
- Earning Date
- SYRE 08-06-2025
- SWIM 08-05-2025
- Dividend Yield
- SYRE N/A
- SWIM N/A
- EPS Growth
- SYRE N/A
- SWIM N/A
- EPS
- SYRE N/A
- SWIM N/A
- Revenue
- SYRE N/A
- SWIM $509,311,000.00
- Revenue This Year
- SYRE N/A
- SWIM $9.24
- Revenue Next Year
- SYRE N/A
- SWIM $5.86
- P/E Ratio
- SYRE N/A
- SWIM N/A
- Revenue Growth
- SYRE N/A
- SWIM N/A
- 52 Week Low
- SYRE $10.91
- SWIM $2.54
- 52 Week High
- SYRE $40.26
- SWIM $8.41
- Technical
- Relative Strength Index (RSI)
- SYRE 51.34
- SWIM 55.42
- Support Level
- SYRE $14.97
- SWIM $6.52
- Resistance Level
- SYRE $16.92
- SWIM $7.00
- Average True Range (ATR)
- SYRE 1.12
- SWIM 0.32
- MACD
- SYRE 0.02
- SWIM 0.03
- Stochastic Oscillator
- SYRE 58.05
- SWIM 65.62
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.